The 9.2% figure is pharma's direct share of NHE, but drugs are a net-positive externality. Cheap statins can stave off cardiac surgeries, GLP-1 can stave off bariatric surgeries, etc. It's ridiculous to conclude we would only save 9.2% on costs--this is not zero-sum.
No comment on drug pricing and its incentives, the existence of America's prescription drug markets drives the new innovative drugs that the rest of the world picks up for cheap.
> Other companies, such as Google and Cloudflare, have the technical means to restrict the blockades to France, but not all providers can do so easily. That includes Quad9, which had no other choice than to apply the French blocking request worldwide.
Just quoting the article, can anyone weigh in on the costs/complexity of a public DNS resolver implementing geo-fencing?